Literature DB >> 1384923

Cytokines in tumour therapy.

A D Hill1, H P Redmond, D T Croke, P A Grace, D Bouchier-Hayes.   

Abstract

Cytokines are low molecular weight proteins released by cells of the immune system that have therapeutic potential in cancer. They include the interleukins, the interferons, tumour necrosis factor and the colony-stimulating factors. Cytokines are capable of producing significant and sustained responses against a number of tumours. Clinically, the highest response rates to cytokine immunotherapy have been seen in melanoma and renal cell cancer. Current efforts aim to reduce treatment-related toxicity while maintaining the efficacy of cytokines. The therapeutic potential of these agents may be increased with genetic manipulation by introducing genes encoding cytokines into tumour-infiltrating lymphocytes and certain tumour cells. However, immunotherapy remains time consuming and expensive, and further developments are necessary before it can have a definitive role in tumour management.

Entities:  

Mesh:

Substances:

Year:  1992        PMID: 1384923     DOI: 10.1002/bjs.1800791005

Source DB:  PubMed          Journal:  Br J Surg        ISSN: 0007-1323            Impact factor:   6.939


  6 in total

1.  Influence of IFN alpha-2b and BCG on the release of TNF and IL-1 by Kupffer cells in rats with hepatoma.

Authors:  X Y Bai; X H Jia; L Z Cheng; Y D Gu
Journal:  World J Gastroenterol       Date:  2001-06       Impact factor: 5.742

2.  The expression of cytokines by an established basal cell carcinoma cell line (BCC-1/KMC) compared with cultured normal keratinocytes.

Authors:  H T Yen; L C Chiang; K H Wen; C C Tsai; C L Yu; H S Yu
Journal:  Arch Dermatol Res       Date:  1996-03       Impact factor: 3.017

3.  Influence of rmhTNF on the chemotherapy treatment of small cell lung cancer.

Authors:  Yang Jin; Xiaonan Tao; Yan Gao; Xianzhi Xiong; Ming Bai
Journal:  J Huazhong Univ Sci Technolog Med Sci       Date:  2006

4.  Spontaneous regression of diffuse intrahepatic recurrence with portal vein tumor thrombus after resection of hepatocellular carcinoma.

Authors:  Akihiro Okano; Hiroshi Takakuwa; Takefumi Nakamura
Journal:  Clin J Gastroenterol       Date:  2010-12-14

5.  In vivo cytokine production and recombinant interleukin 2 immunotherapy: an insight into the possible mechanisms underlying clinical responses.

Authors:  D J Deehan; S D Heys; W G Simpson; J Broom; C Franks; O Eremin
Journal:  Br J Cancer       Date:  1994-06       Impact factor: 7.640

6.  Dipyridamole combined with tumor necrosis factor-alpha enhances inhibition of proliferation in human tumor cell lines.

Authors:  N Suzuki; S Sekiya; I Sugano; T Kojima; H Yamamori; Y Takakubo
Journal:  Jpn J Cancer Res       Date:  1995-08
  6 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.